Phase 0 Biomarker Trials: A New Paradigm for Oncology Drug Development?

Welcome!

My Account
My Cart
Checkout
Log In

Conference Listing
Contact
Help

Search Site Search:

You're currently on :

Home /
Phase 0 Biomarker Trials: A New Paradigm for Oncology Drug Development?

My Cart

Recently Viewed Products

PETER M. GLAZER; Hypoxia and DNA Repair
New Concepts on Tumor-Microenvironment Interactions in Myeloma: Pathophysiological and Therapeutic Relevance
New Concepts in Pathobiology and Therapeutics of Head & Neck Cancer
New Concepts in Lung Cancer: From Bench to Bedside and Beyond

Phase 0 Biomarker Trials: A New Paradigm for Oncology Drug Development?

Session Id: CR08-179 Type: Downloadable

$29.95

Qty:

Brought to you by Conference Media

By using this site you agree to the Terms and Conditions

© 2009 Conference Media. All rights reserved.